Main menu

The potential of ultrarapid nanopore genome sequencing for critical care medicine


Euan Ashley described how he and his team of researchers from Stanford University School of Medicine developed a workflow for ultra-rapid nanopore sequencing that resulted in characterisation of pathogenic variants in under 8 hours. The work used Oxford Nanopore’s high-throughput sequencing device, PromethION 48, and Euan described how his team removed barcoding from the sequencing workflow and used the cloud to help with real-time basecalling and alignment, to reduce the time from sample to variant identification. Overall, Euan noted that he believes the study demonstrated that rapid identification of pathogenic variants has the future potential to guide physicians in clinical management, improve prognosis, and reduce treatment costs.

Authors: Euan Ashley

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag